Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis.
Mase
G
G
Zorzon
M
M
Biasutti
E
E
Vitrani
B
B
Cazzato
G
G
Urban
F
F
Frezza
M
M
D002908:Chronic Disease; D020022:Genetic Predisposition to Disease; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000235:genetics; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins